Rick Proctor

Rick has nearly 30 years of experience in pharma, biotech, and medical devices.

He started Breakthrough Life Sciences LLC, a consulting firm providing strategic, financial, and operational guidance to emerging companies.

Prior to that, Rick was Chief Executive Officer at Glenveigh Medical, an obstetric company developing novel therapeutics (for severe preeclampsia) and surgical instruments (post-partum hemorrhage, vaginal repairs). Glenveigh was the first U.S. distributor for the Monica fetal monitoring device, which was recently acquired by GE Healthcare.

Previous to that, Rick was a marketing and business development executive at GlaxoSmithKline. Rick served on the Board of Directors of the Preeclampsia Foundation for three terms.

Rick received an undergraduate degree from Emory University and an M.B.A. from Wake Forest University.